These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 26861561

  • 1. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM, Xu JF, Fang F, Yang H, Yang LY.
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH, Yu CC, Lin YS, Chen TC, Yeh CT, Liang KH, Shieh TM, Chen CY, Hsueh C.
    Oncotarget; 2016 Jul 12; 7(28):43588-43603. PubMed ID: 27248828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP.
    Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R, Wu S, Lv X, Fang H, Wu S, Kang J.
    J Exp Clin Cancer Res; 2014 Dec 14; 33(1):105. PubMed ID: 25499255
    [Abstract] [Full Text] [Related]

  • 9. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y.
    J Exp Clin Cancer Res; 2019 Jan 08; 38(1):7. PubMed ID: 30621734
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM, Yang H, Fang F, Xu JF, Yang LY.
    Hepatology; 2014 Oct 08; 60(4):1251-63. PubMed ID: 24825302
    [Abstract] [Full Text] [Related]

  • 11. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X, Xu JF, Chang RM, Fang F, Zuo CH, Yang LY.
    Oncotarget; 2016 Jun 28; 7(26):40266-40284. PubMed ID: 27259236
    [Abstract] [Full Text] [Related]

  • 12. Repression of microRNA-130b by thyroid hormone enhances cell motility.
    Lin YH, Wu MH, Liao CJ, Huang YH, Chi HC, Wu SM, Chen CY, Tseng YH, Tsai CY, Chung IH, Tsai MM, Chen CY, Lin TP, Yeh YH, Chen WJ, Lin KH.
    J Hepatol; 2015 Jun 28; 62(6):1328-40. PubMed ID: 25617495
    [Abstract] [Full Text] [Related]

  • 13. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S, Zhang K, Li C, Chen J, Pan Y, Feng B, Lu L, Zhu Z, Wang R, Chen L.
    Oncotarget; 2016 Nov 22; 7(47):78009-78028. PubMed ID: 27793005
    [Abstract] [Full Text] [Related]

  • 14. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 22; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 15. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, Jia Y, Li Q, Zhang H, Tu K, Song T, Liu Q.
    Oncotarget; 2016 Jun 14; 7(24):36909-36923. PubMed ID: 27191994
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J.
    Cancer Lett; 2013 Sep 01; 337(2):226-36. PubMed ID: 23684551
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 18. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 30; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 30; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 20. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B, Feng X, Liu H, Tong R, Wu J, Li C, Yu H, Chen Y, Cheng Q, Chen J, Cai X, Wu W, Lu Y, Hu J, Liang K, Lv Z, Wu J, Zheng S.
    Oncogene; 2020 Oct 30; 39(42):6529-6543. PubMed ID: 32917956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.